10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice - On Demand


10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice - On Demand Banner



Date & Location
Monday, April 4, 2022, 9:00 AM - Monday, October 31, 2022, 11:00 PM

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

This well-received on demand board review provides an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. The 31+ hours of lectures focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

 

An excellent review and update of oncology clinical practice.

World-class speakers!

This is an excellent conference and not just for the boards. I take it every 2-3 years as a refresher and to see what is coming down the pipeline.

- Virtual Course Feedback

Target Audience

The target audience for this program includes medical oncology professionals including physicians, nurses, pharmacists, fellows and residents.

On Demand Content

This on demand course contains over 40 recorded lectures and PDFs of PowerPoint presentations. Select the 'Register' tab at the top of this page to purchase this program. Once you have successfully registered, access to the course materials will be available under the 'Course Content' tab.

Faculty Disclosures

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity and can be viewed by clicking the 'Faculty' tab.

This on demand program will be available for purchase until October 31, 2022.
Access to the videos and claiming credit will be available until January 31, 2023.

Objectives
  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
  3. Prepare for ABIM examinations in medical oncology and hematology

Registration

On Demand Registration Fees

  • Physicians (MDs, PhDs, and DOs): $1,500
  • Residents, Fellows, Nurses, and Other Healthcare Providers: $975
  • Industry Professionals: $2,625

Registration Discounts/Promotions

  • A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend a MSK CME course. If you are a member of one of these groups, please contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected]. 

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

 

Registration for this MSK CME on demand course is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 31.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Recorded/Review Date: March 11-14, 2022; Original Release Date: April 4, 2022; Termination Date: January 31, 2023


Keywords: AMA PRA Category 1